Dr. Landrigan was the first physician in the United States to complete a fellowship in pediatric hospital medicine, and he focused his research on the future of the field and on evaluating efficiency, quality of care, patient experience, and education in pediatric hospitalist systems. His first published papers helped to define the direction of pediatric hospital medicine.
Dr. Landrigan currently is a pediatric hospitalist at Children’s Hospital Boston, where he is also research director of the Children’s Hospital Inpatient Pediatric Service (CHIPS), and is a pediatric hospitalist fellowship director. At CHIPS, he co-authored one of the first papers to examine medication errors and adverse drug events in the pediatric population, which was published in JAMA (Kaushal R, Bates DW, Landrigan C, et al. Medication Errors and Adverse Drug Events in Pediatric Inpatients. JAMA. 2001 Apr(285):2114-2120).
Dr. Landrigan also is director of the Sleep and Patient Safety Program at Brigham and Women’s Hospital, Boston, and is an assistant professor at Harvard Medical School (Boston). His interest in the role of sleep deprivation in patient safety spurred him to work with a team at Harvard on a project assessing the effects of physician/staff sleep deprivation on patient safety.
As project director of the Harvard Work Hours, Health, and Safety Study, he was lead investigator on an October 2005 New England Journal of Medicine study that demonstrated that interns working industry-sanctioned work schedules with recurrent 30-hour shifts made 36% more serious medical errors, and more than five times as many serious diagnostic errors than interns whose scheduled work was limited to 16 consecutive hours (Pennel NA, Liu JF, Mazzini MJ, et al. Interns’ work hours. N Engl J Med. 2005;352:726-728). This study led to other related studies evaluating the effect of industry-sanctioned work schedules, and sleep deprivation and patient safety, resulting in improvements to the standards.
Dr. Landrigan joined SHM in 1998 as a charter member and has served on the Pediatric Committee since 2002. From 2003-2004 he was also a member of the Research Abstract Committee.
Dr. Landrigan earned his undergraduate degree in 1991 and went on to earn his MD from Mount Sinai Medical School, New York City, and his MPH from Harvard School of Public Health, Boston. He completed his residency in pediatrics at Children’s Hospital Boston and his fellowship in general pediatrics there. He joined the Harvard faculty as instructor in 2000, and was promoted to assistant professor in 2004.
Dr. Stucky is recognized as an innovator in pediatrics and has been one of the nation’s most influential pediatric hospitalists. She has participated in landmark projects advancing pediatric medicine, including the establishment of the PRIS network and the development of the nation’s first pediatric hospital medicine core curriculum program to help define the skills and knowledge base needed for the practice of pediatric hospital medicine.
Dr. Stucky is a pediatric hospitalist at San Diego Children’s Hospital-University of California, where she is also director of the Hospital’s Graduate Medical Education. Dr. Stucky also directs the inpatient teaching service for four area-wide pediatric residency programs, oversees a core lecture series for trainees, and serves on multiple UCSD pediatric residency, intern, and education committees. In conjunction with UCSD, Dr. Stucky also participates in a national collaborative research project with the U.S. Department of Veterans Affairs. As site director for the project, she is finalizing data on medication errors and stress management in hospitalists and residents over a one-year period.
In the public policy arena, Dr. Stucky has distinguished herself as an author and a co-author of a number of policy statements. She was the lead author of the AAP’s policy statement “Prevention of Medication Errors in the Pediatric Inpatient Setting,” which outlines the importance of creating an environment of medication safety. On behalf of the AAP, Dr. Stucky challenged the Joint Council on the Accreditation of Healthcare Organizations (JCAHO) on one of its 2004 national patient safety goals requiring that hospitals caring for neonatal and pediatric patients rapidly eliminate the long-standing “rule of 6” method for administering drug dosages in favor of standardized drip concentrations.